首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   134533篇
  免费   10552篇
  国内免费   3199篇
耳鼻咽喉   1256篇
儿科学   7187篇
妇产科学   3822篇
基础医学   13661篇
口腔科学   1577篇
临床医学   13474篇
内科学   20829篇
皮肤病学   2406篇
神经病学   10511篇
特种医学   2731篇
外国民族医学   4篇
外科学   11221篇
综合类   21070篇
现状与发展   16篇
预防医学   7124篇
眼科学   2199篇
药学   6928篇
  65篇
中国医学   20389篇
肿瘤学   1814篇
  2024年   279篇
  2023年   2138篇
  2022年   3830篇
  2021年   6275篇
  2020年   5846篇
  2019年   4411篇
  2018年   4394篇
  2017年   4886篇
  2016年   5043篇
  2015年   4652篇
  2014年   9944篇
  2013年   9653篇
  2012年   8334篇
  2011年   9490篇
  2010年   7370篇
  2009年   6650篇
  2008年   6417篇
  2007年   6565篇
  2006年   5889篇
  2005年   4894篇
  2004年   4112篇
  2003年   3743篇
  2002年   2617篇
  2001年   2376篇
  2000年   2065篇
  1999年   1805篇
  1998年   1518篇
  1997年   1410篇
  1996年   1327篇
  1995年   1317篇
  1994年   1145篇
  1993年   1025篇
  1992年   925篇
  1991年   692篇
  1990年   619篇
  1989年   513篇
  1988年   503篇
  1987年   444篇
  1986年   393篇
  1985年   508篇
  1984年   415篇
  1983年   259篇
  1982年   338篇
  1981年   306篇
  1980年   248篇
  1979年   206篇
  1978年   128篇
  1977年   101篇
  1976年   85篇
  1975年   39篇
排序方式: 共有10000条查询结果,搜索用时 171 毫秒
91.
雄激素不敏感综合征(androgen insensitivity syndrome,AIS)又称为睾丸女性化综合征(testicular feminization syndrome,TFS),是一种X连锁遗传病,是男性假两性畸形中较常见的类型,可分为完全型AIS和不完全型AIS,其原因主要是雄激素受体(androgen receptor,AR)基因的突变导致其对雄激素产生抵抗和不应答。本文回顾南京医科大学附属妇产医院2例CAIS患者的临床资料及诊疗过程,以期能进一步提高对该病的认知及诊治水平。  相似文献   
92.
中医药文化是中医药事业发展的根基和灵魂,社会主义文化建设的重要组成。本文考察改革开放40年以来中医药文化发展的演进过程,从“社会矛盾—政策方针—中医药文化发展”的中观视角,构建了中医药文化发展分析模型,发现中医药文化先后经历了资产化发展(1978年-21世纪初)、情景化发展(21世纪初-中国共产党第十八次全国代表大会(中共十八大)前后)、生态化发展(中共十八大至今)三个阶段,每个阶段中医药文化发展的策略、重点和面临的问题具有明显的不同特点。因此,本文提出以社会矛盾为导向,优化政策引导,构建中医药文化生态体系,从个人、社会和国家发展的不同层面采取多元双向发展路径,推进健康中国发展,提升文化自信,打造文化强国。  相似文献   
93.
目的:回顾性分析芪地固肾方治疗特发性膜性肾病(IMN)的临床疗效与安全性。方法:选取2014年1月至2017年6月陕西中医药大学附属医院肾病科门诊及住院IMN患者141例,根据用药方案分为西药组(西药标准疗法)、中西药结合组(芪地固肾方+西药标准疗法)和中药组(芪地固肾方)3组各47例,观察3组患者治疗后临床疗效、复发率及不良反应等。结果:治疗6个月后,中西药结合组和西药组总有效率72.34%、68.09%高于中药组,治疗12个月时3组有效率比较差异无统计学意义,治疗18个月后中药组和中西药结合组总有效率75.76%、78.72%高于西药组。中药组和中西药结合组在治疗12个月和18个月后较西药组在提高中医证候疗效、减少中医证候积分上更具优势。中药组和中西药结合组复发率更低,3组均未出现严重不良反应。结论:芪地固肾方能提高IMN缓解率,在提高中医证候疗效、降低复发率上更具优势,远期疗效可观,值得进一步推广应用。  相似文献   
94.
吉兰―巴雷综合征(GBS)是一种以快速进行性四肢麻木无力为特点的急性炎性脱髓鞘性多发性多神经根神经病。随着外源性神经节苷脂在临床的广泛应用,该药引起的副作用也逐渐显现,外源性神经节苷脂相关性GBS是其最严重的并发症,临床上主要表现为轴索型GBS,以四肢弛缓性瘫痪为首发症状,表现为急性、严重且快速进展的周围神经受累,较其他轴索型GBS病情重,恢复时间长,预后差。目前发病机制尚不明确。静脉注射人免疫球蛋白是其具有循证医学证据的治疗方法,目前已取代血浆置换成为GBS首选治疗方法,推荐剂量为0.4 g/(kg·d),连续静滴5 d,大剂量激素治疗的效果还有待进一步探讨。早发现、早诊断、尽早停用外源性神经节苷脂、及时应用人血免疫球蛋白冲击治疗和康复治疗,可改善预后。  相似文献   
95.
Gray platelet syndrome (GPS) is a rare (<1/1 000 000) and inherited platelet function disorder characterized by macrothrombocytopenia, α-granule deficiency, and hemorrhages. Bleeding intensity does not correlate with platelet count nor with functional test results. We hereby describe the perioperative bleeding prevention and management of a patient with GPS requiring multiple redo cardiac surgeries.  相似文献   
96.
《Clinical therapeutics》2019,41(5):836-847
PurposeA role for the immune system in causing myalgic encephalopathy/chronic fatigue syndrome (ME/CFS) is long suspected, but few studies have looked for specific autoantibodies that might contribute to the symptoms. Our aim was to look for evidence of antibodies to neuronal proteins in patients with ME/CSF.MethodsSera samples from 50 patients and 50 healthy individuals were sent coded to the Neuroimmunology Laboratory in Oxford. Screening for antibody binding to neuronal tissue was performed on brain tissue and neuronal cultures. Specific serum antibodies were assessed by antigen-specific cell-based assays and radioimmunoassays. After antibody testing, the associations between seropositive status and clinical data were investigated.FindingsOverall, 8 patients and 11 participants were found to have some serum immunoreactivity toward neuronal or neuromuscular junction proteins, but only 1 patient and 2 participants had specific serum antibodies. Nevertheless, seropositive status in patients with ME was associated with shorter duration since onset and a more severe disease.ImplicationsThe results indicate no overall increased frequency of antibodies to neuronal proteins in ME/CSF and no evidence of a specific antibody that might be causative or contribute to clinical features in patients. However, the association of seropositive status with shorter duration of disease and more severe symptoms suggests a possible role of antibodies at onset in some patients and should be the focus of future studies.  相似文献   
97.

Background

In Leriche syndrome, postoperative graft thrombosis remains one of the most significant clinical challenges.

Methods

We reviewed 51 patients who underwent surgery for aortoiliac occlusive disease at our hospital from January 2007 to December 2014. The factors associated with graft patency were determined using the Cox proportional hazard model.

Results

The 2-year prosthetic graft patency rate was 72.5%. Younger age (p = 0.017, Odd ratio (OR) = 1.112), postoperative uncontrolled hypertension (p = 0.044, OR = 3.797), and associated Trans Atlantic Inter-Society Consensus for the Management of Peripheral Arterial Disease II (TASC II) D femoropopliteal lesion (p = 0.008, OR = 11.139) were significantly related factors for prosthetic graft patency after surgical repair. The existing comorbidities of the patients that indicated the need for axillo-bifemoral bypass seemed to be related to lower graft patency or other complications.

Conclusions

For better graft patency after an open surgical repair of Leriche syndrome, strict postoperative hypertension control and distal run-off resolution are necessary.  相似文献   
98.
99.
目的:分析鼻塞式同步间歇正压通气(NIPPV)联合布地奈德雾化治疗ARDS(新生儿急性呼吸窘迫综合征)疾病的临床应用效果。方法:纳入病例是2017年5月—2019年11月收治的104例ARDS新生儿,随机平均分为两组。参照组52例采纳CPAP(持续气道正压通气通气)治疗,实验组52例采纳NIPPV+布地奈德雾化治疗,对比两组呼吸机通气时间、用氧时间、住院时间、血气指标以及并发症发生情况。结果:实验组呼吸机通气时间、用氧时间、住院时间均明显短于参照组,差异有统计学意义P<0.05;实验组治疗3 d后PaCO2明显低于参照组,实验组治疗3 d后PH以及PaO2明显高于参照组,差异有统计学意义P<0.05;实验组并发症发生率(3.85%,2/52)明显低于参照组(21.15%,11/52),差异有统计学意义P<0.05。结论:NIPPV+布地奈德雾化可有效缩短ARDS患者机械通气时间,改善血气指标,降低并发症发生率,值得借鉴。  相似文献   
100.
Abstract

This study is a single-center, retrospective analysis of postmenopausal women presenting with dyspareunia and vulvar pain, aiming to evaluate relative effectiveness of vestibular CO2 laser therapy as a treatment. Three monthly sessions of laser were performed to each patient and thereafter a three-months follow-up was stablished. A total number of 72 patients undergoing vestibular laser treatment were recruited from patient files in the period between 2016 and 2018. Among these, 39 women also received a concomitant treatment with ospemifene (60?mg/day) during the study period. There was a statistically significant reduction of all the symptoms in both groups up to the three month follow-up. Regarding dryness and dyspareunia, the relief tent to be more prominent in the ospemifene?+?laser group at all follow-ups and remained statistically significant at three-month follow-up. Specifically, vestibular dryness was significantly lower in the ospemifene?+?laser group compared with the laser treatment group (?87% vs???34%, respectively), and the vestibular health score started declining faster in the ospemifene?+?laser group. Although, additional research is needed to understand the mechanism of action, our data shows that a combination regimen of laser and ospemifene may improve clinical effectiveness for long-term treatment of symptoms associated with the under-recognized genitourinary syndrome of menopause.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号